Next-generation cancer drugs will take aim with unprecedented certainty, but making them requires a new discovery and development paradigm. By Malorye A. BrancaRemaking the FDA
New commissioner is pushing for greater use of technology and innovation to speed the flow of drugs to market. By Brian ReidNews·Analysis Research IP ‘Harbor’ No Longer Safe?FightAIDS@Home Enters Phase TwoContemplating Bioethics’ Prickly PearGlobal Network Paves the Way for Better InternetToward More Targeted MedicinePutting the Y in (Wise) GuyLeveraging the Chimp Genome for HIV ResearchGoldfarb Goes to IBMPharma’s MeccaRNAi Dominates ‘Beyond Genome’ DiscussionsHorizonsPlaying by Aussie RulesGTG's Mervyn Jacobson discusses the controversial patenting of non-coding DNA.Orphan Drugs: For Love or Money?Entrepreneurs organize to work toward cures for rare "orphan" diseases.Discovery Surges and Tools DeliverMarket Compass for Q2 finds consolidation continuing, but market caps rising.Beyond the BlockbusterGenomics and big hits are not mutually exclusive, writes Deloitte & Touche's life sciences expert.Columns & DepartmentsFirst Base | Kevin DaviesA maverick scientist and entrepreneur finds himself at the center of a DNA patenting storm.Nothing Ventured... | Michael A. GreeleyAre venture capitalists still looking for "the killer app"? Funding the next big idea won't be so easy.Fully Equipped |By Robert M. FredericksononSciQuest customizes its global marketplace Web portal to better meet customer needs.The Dodge Retort | John DodgeIntegration and the real-time enterprise: "Knowledge is the differentiator."New ProductsGeneXP Does Well with Microplate-based System· ABI/Millipore Kit Hits the MALDIspot· MathWorks Tools Grab Image Data Letters
For reprints and/or copyright permission, please contact Jay Mulhern, (781) 972-1359, email@example.com.
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: firstname.lastname@example.org
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesreportsbarnett educational servicesconsultingpublications & eNewslettersprofessional services
executive teamtestimonialschi timelinemailing listcareers